Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
García Hernandez S., de la Higuera Romero L., Fernandez A., Luisa Peña Peña M., Mora-Ayestaran N., Basurte-Elorz M.T., Larrañaga-Moreira J.M., Cárdenas Reyes I., Villacorta E., Valverde-Gómez M., Baustista-Paves A., Veira Villanueva E., Ortiz-Genga M., Lipov A., Brogger N., Sabater Molina M., Moreno-Escobar E., Ruiz-Guerrero L., Syrris P., Fernández X., Piqueras-Flores J., Amor Salamanca A., Bezzina C.R., Elliott P.M., Barriales-Villa R., Gimeno-Blanes J.R., García-Pavía P., Walsh R., Ochoa J.P. Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants. Circulation. 14 October 2025. 152:1060-1075. 10.1161/CIRCULATIONAHA.125.074529
AÑO: 2025; IF: 38.6
40879562
Garcia-Pavia P, Maron MS, Masri A, Merkely B, Nassif ME, Pena-Pena ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, Correia EB, Dybro AM, Elliott P, Hegde SM, Lakdawala NK, Lewis GD, Mann A, Miao ZM, Nair A, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA; MAPLE-HCM Investigators. Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2025 Sep 11;393(10):949-960. doi: 10.1056/NEJMoa2504654. Epub 2025 Aug 30. PubMed PMID: 40888697.
AÑO: 2025; IF: 78.5
40888697
Soler-Espejo E., Marín F., López-Gálvez R., Ramos-Bratos M.P., Sánchez-Villalobos M., Esteve-Pastor M.A., Lip G.Y.H., Rivera-Caravaca J.M., Roldán V. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study. Clinical Cardiology. February 2025. 48. 10.1002/clc.70102
AÑO: 2025; IF: 2.3
39985306
Soler-Espejo E, Marin F, Lopez-Galvez R, Ramos-Bratos MP, Sanchez-Villalobos M, Esteve-Pastor MA, Lip GYH, Rivera-Caravaca JM, Roldan V. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study. Clin Cardiol. 2025 Feb;48(2):e70102. doi: 10.1002/clc.70102. PubMed PMID: 39985306; PubMed Central PMCID: PMC11845907.
AÑO: 2025; IF: 2.3
39985306
Larranaga-Moreira JM, Ochoa JP, Peteiro-Deben R, Martin-Alvarez E, Ripoll-Vera T, Alvarez-Rubio J, Pena-Pena ML, Llamas-Gomez H, Fernandez A, Gallego-Delgado M, Rodriguez-Serrano AI, Diez-Lopez C, Elliott PM, Palomino-Doza J, Lorca R, Limeres J, Azevedo O, Zorio E, Martin-Dorado E, Mendez-Fernandez I, Franco-Gutierrez R, de Frutos F, Escudero A, Ruiz-Guerrero L, Rodriguez-Vilela A, Mazzanti A, McKenna WJ, Barriales-Villa R; TNN Investigators. The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy. JACC Heart Fail. 2025 Apr 30:102419. doi: 10.1016/j.jchf.2025.01.024. Online ahead of print. PubMed PMID: 40310325.
AÑO: 2025; IF: 11.8
40310325
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

CARDIOLOGIA CLINICA Y EXPERIMENTAL